Trade Summary

2 months ago, Strome Mark E, serving as 10% owner at Zivo Bioscience, Inc. (ZIVO), purchased 20,000 shares at $9.77 per share, for a total transaction value of $195,400.00. Following this transaction, Strome Mark E now holds 472,942 shares of ZIVO.

This purchase represents a 4.00% increase in Strome Mark E's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, February 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, February 17, 2026, 5 days after the trade was made.

Zivo Bioscience, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.